93 related articles for article (PubMed ID: 10545793)
1. Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients.
Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi SY; Shim KS; Han WS
Oncology; 1999 Oct; 57(3):236-41. PubMed ID: 10545793
[TBL] [Abstract][Full Text] [Related]
2. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients.
Choi JH; Oh JY; Ryu SK; Kim SJ; Lee NY; Kim YS; Yi SY; Shim KS; Han WS
Cancer; 1997 May; 79(10):1879-83. PubMed ID: 9149012
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer.
Balcan E; Demirkiran F; Aydin Y; Sanioglu C; Bese T; Arvas M; Akçay T; Cift T
Int J Gynecol Cancer; 2012 Sep; 22(7):1138-42. PubMed ID: 22914212
[TBL] [Abstract][Full Text] [Related]
4. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay.
Chien CH; Huang CC; Lin YH; Shen J; Chow SN
Gynecol Oncol; 1997 Sep; 66(3):405-10. PubMed ID: 9299253
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.
Moskal TL; Huang S; Ellis LM; Fritsche HA; Chakrabarty S
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):127-31. PubMed ID: 7742720
[TBL] [Abstract][Full Text] [Related]
6. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma.
Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(6B):4489-93. PubMed ID: 11205293
[TBL] [Abstract][Full Text] [Related]
7. Increased serum levels of transforming growth factor-alpha in patients with colorectal cancer.
Shim KS; Kim KH; Park BW; Yi SY; Choi JH; Han WS; Park EB
Dis Colon Rectum; 1998 Feb; 41(2):219-24. PubMed ID: 9556248
[TBL] [Abstract][Full Text] [Related]
8. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of rare and complex mutations in EGFR and serum levels of soluble EGFR and its ligands in non-small cell lung carcinoma patients.
Haghgoo SM; Khosravi A; Mortaz E; Pourabdollah-Toutkaboni M; Seifi S; Sabour S; Allameh A
Clin Biochem; 2017 Apr; 50(6):293-300. PubMed ID: 27923629
[TBL] [Abstract][Full Text] [Related]
10. Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.
Ishikawa N; Daigo Y; Takano A; Taniwaki M; Kato T; Hayama S; Murakami H; Takeshima Y; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
Cancer Res; 2005 Oct; 65(20):9176-84. PubMed ID: 16230376
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer.
Masago K; Fujita S; Hatachi Y; Fukuhara A; Sakuma K; Ichikawa M; Kim YH; Mio T; Mishima M
Cancer Sci; 2008 Nov; 99(11):2295-301. PubMed ID: 18811692
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer.
Saltzman AK; Hartenbach EM; Carter JR; Contreras DN; Twiggs LB; Carson LF; Ramakrishnan S
Gynecol Obstet Invest; 1999; 47(3):200-4. PubMed ID: 10087418
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection.
Shim KS; Kim KH; Han WS; Park EB
Cancer; 1999 Feb; 85(3):554-61. PubMed ID: 10091729
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus.
Koyama S; Ikeda K; Sato M; Shibahara K; Yuhara K; Fukutomi H; Fukunaga K; Kanazawa N; Yuzawa K; Fukao K; Iijima T; Kikuchi M; Tomiya T; Fujiwara K
J Gastroenterol; 1997 Feb; 32(1):71-7. PubMed ID: 9058298
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
Lin Y; Kikuchi S; Obata Y; Yagyu K;
J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma.
Kawabata T; Ichikura T; Majima T; Seki S; Chochi K; Takayama E; Hiraide H; Mochizuki H
Cancer; 2001 Oct; 92(8):2050-5. PubMed ID: 11596019
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients.
Hur H; Yu EJ; Ham IH; Jin HJ; Lee D
Oncotarget; 2017 Feb; 8(7):10994-11003. PubMed ID: 28036255
[TBL] [Abstract][Full Text] [Related]
20. Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21.
Addison CL; Ding K; Zhao H; Le Maître A; Goss GD; Seymour L; Tsao MS; Shepherd FA; Bradbury PA
J Clin Oncol; 2010 Dec; 28(36):5247-56. PubMed ID: 21079146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]